Jennifer Kate van Heerden
5PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 13, 2025
Longer-term virologic outcomes on tenofovir-lamivudine-dolutegravir in second-line ART.Jennifer K van Heerden, Ying Zhao, Claire M Keene
|Sep 13, 2024
Scoping review of post-TB pulmonary vascular disease: Proceedings from the 2nd International Post-Tuberculosis Symposium.Elizabeth H Louw, Jennifer A Van Heerden, Ismail S Kalla
|Feb 26, 2024
Relationship Between Tenofovir Diphosphate Concentrations in Dried Blood Spots and Virological Outcomes After Initiating Tenofovir-Lamivudine-Dolutegravir as First-Line or Second-Line Antiretroviral Therapy.Jennifer Kate van Heerden, Graeme Meintjes, David Barr
|Jan 17, 2024
The prevalence of pulmonary hypertension in post-tuberculosis and active tuberculosis populations: a systematic review and meta-analysis.Jennifer K van Heerden, Elizabeth H Louw, Friedrich Thienemann
|Jul 12, 2023
Cutaneous tuberculosis: An infrequent manifestation of a common pathogen in South Africa.Jennifer K van Heerden, Alistair G B Broadhurst, Ruan S de Jager
Pageof 1
Frequent Collaborators
2 joint publications
Elizabeth H Louw
2 joint publications
Friedrich Thienemann
2 joint publications
Brian W Allwood
2 joint publications
Graeme Meintjes
1 joint publications
Ismail S Kalla
1 joint publications
Gerald J Maarman
1 joint publications
Zoliswa Nxumalo
1 joint publications
Moises A Huaman
1 joint publications
Matthew Magee
1 joint publications
Alistair G B Broadhurst
